Market Tracker

02/12 1:15pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

2.07
Delayed Data
As of 12:54pm ET
 +0.02 / +0.98%
Today’s Change
1.75
Today|||52-Week Range
5.48
-14.46%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close2.05
Today’s open2.09
Day’s range1.99 - 2.12
Volume13,556
Average volume (3 months)233,247
Market cap$91.0M
Dividend yield--
Data as of 12:54pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+43.83%
Earnings growth (this year)+15.02%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+349.95%
P/E ratioNM
Price/Sales26.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...+0.03+1.04%
XOMAXOMA Corp+0.01+0.74%
PRQRProQR Therapeutics N...+0.04+1.02%
SMMTSummit Therapeutics ...0.000.00%
Data as of 1:00pm ET, 02/12/2016

Financials

Last reporting dateFebruary 12, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$8.4M
Annual profit (last year)-$36.7M
Net profit margin-435.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts